| Hauck, Simone (Norgenta 201211 Manager Marketing + PR) |
Sales Manager / Marketing Manager |
Hamburg (govt region) |
Germany |
| Hauck, Stefanie (Helmholtz 201202 Deputy Head Research Unit Protein Science at Helmholtz-Zentrum München) |
Researcher (university / research institute) |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Hauer, Andreas (Savira Pharmaceuticals 201210– CFO before Erste Group Bank + Igeneon) |
Chief Financial Officer (CFO) |
Savira Pharmaceuticals GmbH |
Austria |
| Hauffe, Dietrich (Bruker 201508– EVP Life Sciences Mass Spectrometry at Bruker Daltonics before Qiagen + Dionex) |
President/Director/Head Business Group/Unit/Division |
Bruker Corporation (Group) |
United States (USA) |
| Haug, Matthias (Bayer 201206 Head of Seed Treatment at Bayer CropScience) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Haug, Peter (Oncgnostics GmbH 201501 Business Development + Licensing Manager) |
Business Development Manager / Strategy Manager |
Oncgnostics GmbH |
Germany |
| Haugg, Norbert |
n. a. |
Deutsches Patent- und Markenamt |
Germany |
| Hauke, Sven (ZytoVision GmbH 200405–200902– Managing Director + founder before Alcedo Biotech) |
Managing Director |
ZytoVision (Group) |
Germany |
| Haunhorst, Eberhard (Niedersachsen (govt) 201407 President of LAVES) |
Administrative Officer (personnel) |
Niedersachsen (govt region) |
Germany |
| Haupt, Lena (Hessen (govt) 201411 Project Manager Life Sciences at Hessen Trade & Invest) |
Cluster Manager |
Hessen (govt region) |
Germany |
| Haupts, Ulrich (Coral BioNet 201109– CSO of Scil Proteins GmbH before Bayer + Direvo Biotech + SKB UK) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
UV-Cap (Group) |
Germany |
| Haurum, John (F-Star 201205–201810 CEO before ImClone System + Symphogen LEFT 10/18) |
Chief Executive Officer (CEO) |
F-Star (Group) |
United Kingdom (GB) |
| Hausch, Marcus |
n. a. |
febit (Group) |
Germany |
| Hausdorf, Gabriele (Germany (govt) 201005 BMBF) |
Governmental Officer / Adminstrative Officer |
Germany (govt) |
Germany |
| Havey, Adam (Emergent BioSolutions 201412 EVP + President Biodefense division) |
President/Director/Head Business Group/Unit/Division |
Emergent BioSolutions (Group) |
United States (USA) |
| Havlina, Roxana (Rovalab 201104 Managing Director) |
Managing Director |
Rovalab GmbH |
Germany |
| Hawa, Gerhard Hawa (Fianostics GmbH 201510 CEO) |
Chief Executive Officer (CEO) |
Fianostics GmbH |
Austria |
| Hawkins, Rick (Lumos Pharma 201604 CEO) |
Chief Executive Officer (CEO) |
Lumos Pharma (US) |
United States (USA) |
| Hawkins, Tim (Schauenburg 201308– Finance Director at Markes Intl before PriceWaterhouseCoopers) |
Chief Financial Officer (CFO) |
Schauenburg (Group) |
United Kingdom (GB) |
| Hawkins, Trevor (ProGenTech 200810 Chairman + CEO) |
Chief Executive Officer (CEO) |
ProGenTech (Group) |
United States (USA) |
| Hayday, Adrian (Professor + Co-Founder of ImmunoQure) |
n. a. |
ImmunoQure (Group) |
Germany |
| Hayden, Michael (Teva 201307 President Global RnD + CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Teva (Group) |
Israel |
| Hays, Anne (Lonza 201412 Head Custom Development Services Organisation) |
Business Development Manager / Strategy Manager |
Lonza Group (Group) |
Switzerland |
| Hayward, Colin (Myriad 201501 European Medical Director) |
n. a. |
Myriad Genetics (Group) |
United States (USA) |
| Hazenberg, Wil (BioGeneration Ventures 201112 Partner) |
Partner (venture partner) |
BioGeneration Ventures B.V. (BGV) |
Netherlands |
| Headly, Martin S. (Brooks Automation –201309 CFO LEFT 9/13) |
Chief Financial Officer (CFO) |
Brooks Automation (Group) |
United States (USA) |
| Healy, James I. (Jim) (Sofinnova Ventures 200701 General Partner) |
General Partner (venture partner) |
Sofinnova (Group) |
United States (USA) |
| Hecht, Frank (CellGenix 201702 VP Marketing + Sales) |
Sales Manager / Marketing Manager |
CellGenix (Group) |
Germany |
| Hecht, Peter (Oridis Biomed 200502– CEO before Tripos) |
Chief Executive Officer (CEO) |
Oridis Biomarkers GmbH |
Austria |
| Hecht, Robert (Olympus 200812 Managing Director Olympus Diagnostics Europe) |
Managing Director |
Olympus (Group) |
Germany |
| Hecht, Thomas (Delenex 201105 Board Chairman + Affimed 201112 Board Chairman) |
Board member, non-executive |
Cell Medica (Group) |
Switzerland |
| Heck, Albert J. R. (Univ Utrecht 199809– Prof + Head Biomolecular Mass Spec & Proteomics Group) |
Professor |
University of Utrecht (Utrecht University) |
Netherlands |
| Hecker, Michael (Univ Greifswald 201312 Professor) |
Professor |
University of Greifswald |
Germany |
| Heckl, Wolfang M. (LMU München 200505) |
n. a. |
LMU Munich (Ludwig-Maximilians-Universität München) |
Germany |
| Heckle, Sven (Börse Inside 200511) |
n. a. |
Börse Inside AG |
Germany |
| Hedegaard, Anders (Bavarian Nordic 200708– CEO) |
Chief Executive Officer (CEO) |
Bavarian Nordic (Group) |
Denmark |
| Hediard, Florent (SGS 201610 Life Sciences Marketing Director Agriculture + Food + Life) |
Sales Manager / Marketing Manager |
SGS (Group) |
Switzerland |
| Hédou, Gaël (Relief Therapeutics 201610 COO) |
Chief Operating Officer (COO) |
Relief Therapeutics (Group) |
Switzerland |
| Heeger, Steffen (Selvita 201802– CMO before MorphoSys 201312– Head of Clinical Research before Merck Serono) |
Chief Medical Officer (CMO) |
Selvita (Group) |
Poland |
| Heeren, Ron M. A. (Maastricht Univ 2015 Co-Director of M4I Institute before FOM Amsterdam 200808) |
Professor |
Maastricht University (Universiteit Maastricht, UM) |
Netherlands |
| Hegendörfer, Thomas (Max Planck 201104 Head Business Development of Lead Discovery Center GmbH) |
Business Development Manager / Strategy Manager |
Max Planck Society for the Advancement of Science |
Germany |
| Heggie, Theresa (Alnylam 201808 Head of Europe before Shire 200903 CEO Jerini AG) |
Regional manager |
Alnylam (Group) |
United States (USA) |
| Hehman, Hilary (Fred Hutchinson 201805 Director of Partnerships + Alliances) |
Business Development Manager / Strategy Manager |
Fred Hutchinson Cancer Research Center (Seattle, WA) |
United States (USA) |
| Heibel, Hauke (microDimensions GmbH 2011– Managing Director (CTO) + Co-founder) |
Managing Director |
microDimensions GmbH |
Germany |
| Heiberger, Kurt (Eyesight & Vision 201006– Managing Director + Co-founder) |
Managing Director |
Eyesight & Vision GmbH |
Germany |
| Heidecker, Martin (Boehringer 201201 Director at Boehringer Ingelheim Venture Fund) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim Venture Fund (BIVF) |
Germany |
| Heiden, Stefanie (DBU + Univ Osnabrück 200501) |
n. a. |
Deutsche Bundesstiftung Umwelt DBU |
Germany |
| Heidtke, Karsten (Atlas Biolabs 201009 Head Bioinformatics) |
n. a. |
Atlas Biolabs GmbH |
Germany |
| Heikenwälder, Mathias (Helmholtz 201904 Prof + Group Leader at DKFZ) |
Researcher (university / research institute) |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Heiker, Fred-Robert (Bayer) |
n. a. |
Bayer (Group) |
Germany |
| Heim, Jutta (Evolva –201304 CSO STEPPED DOWN 4/13 before CTO before Basilea CSO + Novartis) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Evolva (Group) |
Switzerland |
| Heimbrook, David (Roche 200310) |
n. a. |
Roche (Group) |
Switzerland |
| Heimer, Jon (Olink 201510 CEO) |
Chief Executive Officer (CEO) |
Olink (Group) |
Sweden |
| Hein, Frauke (Deutsche Biotech Innovativ 201211 Managing Director of MLDx GmbH + Adrenomed) |
Managing Director |
Deutsche Biotech Innovativ (Group) |
Germany |
| Heine, Birgit (Sachsen Anhalt (govt) 201301 Senior Manager Life Sciences at IMG) |
Cluster Manager |
Saxony-Anhalt (govt region) |
Germany |
| Heiniö, Jussi (Sartorius 201112– before Biohit CEO) |
Chief Executive Officer (CEO) |
Sartorius (Group) |
Germany |
| Heinrich, Günther (Epidauros Founder) |
Company Founder |
Danaher (Group) |
Germany |
| Heinrich, Peter (Sinfonie LS 201206– Managing Director before MagForce + MediGene 1995–200904 CEO + founder) |
Board member |
BIO Deutschland e. V. |
Germany |
| Heinrichs, Hubert (Antisense Pharma 201012 Managing Director) |
Managing Director |
Isarna Therapeutics GmbH |
Germany |
| Heintze, Déborah (Lunaphore Technologies 201404– COO + Co-Founder) |
Chief Operating Officer (COO) |
Lunaphore Technologies S.A. |
Switzerland |
| Heinz, Dirk (Helmholtz 201108– Scientific Director of HZI Braunschweig since 1998 at GBF/HZI) |
President/Director/Head Business Group/Unit/Division |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Heinzen, Christoph (Alicon AG 200810 CEO) |
Chief Executive Officer (CEO) |
Alicon AG |
Switzerland |
| Heise, Tim (Profil GmbH 201403 Managing Director) |
Managing Director |
Profil Institut für Stoffwechselforschung GmbH |
Germany |
| Helbig, Ingo (Univ Kiel 201203 Professor Dept of Neuropediatrics UKSH Kiel) |
Professor |
University of Kiel (Christian-Albrechts-Universität, CAU) |
Germany |
| Helbling, Paul (Dualsystems Biotech 201309 Business Development Sales and Marketing) |
Business Development Manager / Strategy Manager |
Dualsystems Biotech (Group) |
Switzerland |
| Heldt, Markus (BASF 201310 President of Crop Protection division) |
President/Director/Head Business Group/Unit/Division |
BASF (Group) |
Germany |
| Helftenbein, Elke (Antigene Biotech GmbH –201201 Managing Director) |
Managing Director |
Antigene Biotech GmbH |
Germany |
| Hélin, Guy (Syngulon 201809 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Syngulon S.A. |
Belgium |
| Hell, Stefan W. (Max Planck 201503 Director at MPI for biophysical Chemstry in Göttingen) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
| Helle, Norbert (TeLa GmbH 200902 Managing Director) |
Managing Director |
Sirius Fine Chemicals SiChem GmbH |
Germany |
| Heller, Barbara (Santhera 200701 CFO) |
Chief Financial Officer (CFO) |
Santhera (Group) |
Switzerland |
| Heller, Damian (Basilea 201708– General Counsel + Corp Secretary joined 2015 before Novartis Pharma + Syngenta) |
General Counsel / Chief Legal Officer (CLO) |
Basilea (Group) |
Switzerland |
| Heller, Manfred (Univ Bern 201109 Head Proteomics + Mass Spec Core Facility) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Bern |
Switzerland |
| Hellmann, Arndt (CMS 201408 Head of Public & Media Relations CMS Hasche Sigle Berlin) |
Public Relations Manager / Investor Relations Manager |
CMS (Group) |
Germany |
| Hellmann, Carsten (ALK 201701– CEO before Sanofi SVP CEO of Merial) |
Chief Executive Officer (CEO) |
ALK (Group) |
Denmark |
| Hellwage, Jens (InfectoGnostics 201504 Managing Director) |
Cluster Manager |
InfectoGnostics Research Campus Jena (InfectoGnostics Forschungscampus Jena e. V. ) |
Germany |
| Helmling, Steffen (Noxxon 200603 VP BusDev US) |
Business Development Manager / Strategy Manager |
Noxxon Pharma AG |
Germany |
| Heltovics, Gábor (Druggability Technologies 201406 CEO before Solvo Biotechnology 200603 Director BusDev) |
Chief Executive Officer (CEO) |
Druggability Technologies (DRGT) (Group) |
Ireland, Republic of |
| Hemker, Claus (SCOPE Life Sciences 201004 Managing Director) |
Managing Director |
SCOPE Life Sciences GmbH |
|
| Hemme, Philip (Labiotech.eu Co-Founder) |
Company Founder |
Labiotech.eu UG (haftungsbeschränkt) |
Germany |
| Henchoz, Stéphane (Auven Therapeutics 201409– Director of Finance at ADC Therapeutics before Merck Serono) |
Chief Financial Officer (CFO) |
Auven Therapeutics (Group) |
Switzerland |
| Henco, Karsten (HS LifeSciences 200901 President + former founding investor of Qiagen + Evotec et al) |
Investment Manager |
HS LifeSciences (Group) |
Switzerland |
| Henderson, Ian (MCF Corporate Finance 201612) |
consulting (economic) |
MCF Corporate Finance |
Germany |
| Hendricson, Adam (BMS 201111 Lead Evaluation at BMS, C, US) |
Researcher (industry) |
Bristol-Myers Squibb (BMS) (Group) |
United States (USA) |
| Hendriks, Stefan (Novartis 201807 Global Head of Biopharmaceuticals at Sandoz) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Germany |
| Hengster, Ingrid (Germany (govt) 201505 Exective Board Member of KfW) |
Board member, executive |
Germany (govt) |
Germany |
| Hengstermann, Theo (Optimare 201004 CEO) |
Chief Executive Officer (CEO) |
Aerodata (Group) |
Germany |
| Henig, Noreen Roth (201807– CMO before ProQR Therapeutics + Gilead Sciences) |
Chief Medical Officer (CMO) |
Breath Therapeutics (Group) |
Germany |
| Henke, Heinz-Werner (Innovative Tomography Products GmbH 201305 Managing Director) |
Managing Director |
Innovative Tomography Products GmbH (ITP Innotom) |
Germany |
| Henkel, Thomas (IMD Natural Solutions 201508 Managing Director + Co-Founder + Imax Discovery before Bayer) |
Managing Director |
IMD Natural Solutions (INS) (Group) |
Germany |
| Henkel, Thomas (Targos Molecular Pathology GmbH 201201 Managing Director) |
Managing Director |
Targos Molecular Pathology GmbH |
Germany |
| Henn, Hans-Joachim (Bayer 201606 Global Head of Anti-Counterfeit Management) |
n. a. |
Bayer (Group) |
Germany |
| Hennecke, Anne (MC Services 201211 Managing Partner before Evotec + Schwarz Pharma) |
public relations / investor relations |
MC Services AG |
Germany |
| Hennecke, Jens (PPF Group 201503– CBO at Sotio as before Micromet VP BusDev) |
Chief Business Officer (CBO) |
PPF Group (Group) |
Czech Republic |
| Hennemann, Hanjo (VeroVaccines GmbH 201707– Managing Direcotor + CO-Founder before Nexigen GmbH) |
Managing Director |
VeroVaccines GmbH |
Germany |
| Hennig, Christian (Zellkraftwerk 201301) |
Company Founder |
Canopy Biosciences (Group) |
Germany |
| Henrichsen, Frank (Nanion Technologies 201601– Director of Global Sales before Sophion Bioscience) |
Sales Manager / Marketing Manager |
Nanion (Group) |
Germany |
| Hensel, Frank (High-Tech Gründerfonds 201603) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Hentsch, Bernd (4SC 201009–201403 Chief Development Officer LEFT 3/14) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
4SC (Group) |
Germany |
| Hentschel, Norbert (Miltenyi Biotec 201308 Managing Director) |
Managing Director |
Miltenyi Biotec (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 22 23 24 ... 65 66 67 
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lse-life-sciences-europe-com.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
